Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19Leora R. Feldstein, Adrienne G. Randolph, Mark W. Tenforde et al.|JAMA|2021Cited by 852
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory SyndromeKerri L. LaRovere, First Name and Middle Initial Last Name, Leora R. Feldstein et al.|JAMA Neurology|2021Cited by 405
Multisystem Inflammatory Syndrome in Children — Initial Therapy and OutcomesMary Beth F. Son, Adrienne G. Randolph, Nancy L. Murray et al.|New England Journal of Medicine|2021Cited by 380
Development of a Quality Improvement Learning Collaborative to Improve Pediatric Sepsis OutcomesGitte Larsen, Richard J. Brilli, Charles G. Macias et al.|PEDIATRICS|2020Cited by 62
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescentsAlon Geva, Adrienne G. Randolph, Manish M. Patel et al.|EClinicalMedicine|2021Cited by 35